gms | German Medical Science

7th EFSMA – European Congress of Sports Medicine, 3rd Central European Congress of Physical Medicine and Rehabilitation, Annual Assembly of the German and the Austrian Society of Physical Medicine and Rehabilitation

Austrian Society of Physical Medicine and Rehabilitation

26.-29.10.2011, Salzburg, Austria

OA and DMOAD literature overview

Meeting Abstract

Search Medline for

7th EFSMA – European Congress of Sports Medicine, 3rd Central European Congress of Physical Medicine and Rehabilitation. Salzburg, 26.-29.10.2011. Düsseldorf: German Medical Science GMS Publishing House; 2011. Doc11esm078

DOI: 10.3205/11esm078, URN: urn:nbn:de:0183-11esm0789

Published: October 24, 2011

© 2011 Edtinger.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

OA and DMOAD take a look at the literature: Osteoarthritis is a chronic degenerative disease with multifunctional etiology characterized by the gradual loss of joint cartilage and the degredation of synovial fluid. OA is one of the most declared chronic diseases affecting more than 50% of the population over 64 years of age in the U.S. More than 5 Million are given the diagnosis every year. An immense social impact is seen due to pain and limitation of movement which affects quality of life and changes habits. Conservative treatment of course includes physical activity and in a number of cases physical therapy, but the field of Structure and Disease modifying anti OA drugs is becoming more important due to significant advantages in a long term therapy. Goal is to give a literature overview on OA drug regimes focusing on the S/DMOADs.